Creatine Kinase ? 1.5x the upper limit of normal
Dermatomyositis with a creatine phosphokinase (CPK) level above normal or with an active skin rash or scleroderma
Creatine phosphokinase (CPK) ? 2.5 × ULN.
Creatine kinase (CPK) =< 1.5 x ULN.
Creatine kinase measurement (CPK) 250 mg/dL
Creatine kinase (CK)-MB =< ULN
Creatine phosphokinase (CPK) ? ULN obtained ? 14 days prior to randomization
creatinine phosphokinase isozymes CPK-MB and CPK-MM ? ULN;
Patients with serum creatine >= 1.5 mg/dL
Serum CK/CPK ?2.5 x ULN.
Troponin-I, creatine kinase muscle and brain (CK-MB), B-type natriuretic peptide (BNP) =< ULN
Troponin-I, creatine kinase MB (CK-MB), B-type natiuretic peptide (BNP) =< ULN
Plasma creatinine phosphokinase (CK) < 1.5 x ULN
Plasma creatine phosphokinase (CK) < 1.5 x ULN
Plasma creatine phosphokinase (CK) < 1.5 x ULN
Creatine > 2.5 mg/dl
Creatine kinase (CPK) =< 2.5 x ULN
Subjects with creatine kinase > ULN
Creatine kinase < 5 X institutional ULN
Creatine phosphokinase (CPK) ? 2.5 × ULN.
Creatine phosphokinase (CPK) < 2.5 X ULN
Plasma creatine phosphokinase (CK) less than 1.5 x ULN
Plasma creatine phosphokinase (CK) < 1.5 x ULN
Creatine kinase (CK) =< 2.5 times the upper limit of normal
Has neuromuscular disorders associated with an elevated creatine kinase
Plasma creatine phosphokinase (CK) < 1.5 x upper limit of normal (ULN)
Plasma creatinine phosphokinase (CK) < 1.5 x ULN
Creatinine phosphokinase (CPK) within 2.5 x upper limit of normal (CTCAE 4.0 grade 1 abnormality is acceptable)
Patients with baseline creatinine kinase (CK) > ULN
Creatine phosphokinase =< institutional upper limit of normal
Creatine: =< 2 mg/dL
Plasma creatine phosphokinase (CK) < 1.5 x ULN, if known
The subject has creatine phosphokinase (CPK) elevation NCI CTCAE grade greater than equal to (>=) 2, and/or a previous history of myositis or rhabdomyolysis.
Serum CK ?1.5 ULN
Creatine phosphokinase (CPK) ?2.5 × the ULN.
Plasma creatine phosphokinase (CK) < 1.5 x ULN
Adequate organ function as evidenced by the following peripheral blood counts or serum chemistry values: hemoglobin 9 gram per deciliters (g/dL), absolute neutrophil count (ANC) 1,500/L, platelet count 100,000/L, serum creatinine 1.5*the upper limit of normal (ULN), creatine phosphokinase (CPK) 2.5 Upper Limit of Normal [ULN]
Patients must have no signs of significant rhabdomyolysis determined by creatine phosphokinase (CPK) levels with a creatine kinase (CK) < 5 times the upper limit of normal
Creatine phosphokinase (CPK) =< the institutional upper limit of normal
Plasma creatine phosphokinase (CK) < 1.5 x ULN
History or presence of myopathy or raised creatine kinase (CK) >5 x upper limit of normal (ULN) on 2 occasions at screening.
Creatine phosphokinase (CPK) =< 2.5 x ULN
Creatine phosphokinase (CPK) =< 2.5 x ULN